Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of Risperidone for irritability in children and adolescents with auti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Autistic Disorder in Children and Adolescents | Phase 3 | Status: COMPLETED